Resources
- sort by:
- Relevance
- Date
- Popularity
- Eli Lilly settles Zyprexa suit for $1.42-billion
- NEW YORK — Drug maker Eli Lilly is pleading guilty to a charge that it illegally marketed anti-psychotic drug Zyprexa for off-label use, and will pay a combined $1.42-billion (U.S.) to settle civil suits and end the criminal investigation. The Indianapolis-based company will pay $800-million to settle civil suits, including...
- News items 2009-08-07
- ELI LILLY ASIA VC FUND SETTLES IN SHANGHAI
- AsiaInfo Services 11-16-2007 Eli Lilly Asia VC Fund Settles in Shanghai BEIJING, Nov 16, 2007 SinoCast via COMTEX -- World's well-known pharmaceutical company US-based Eli Lilly and Company announced on November 14 that the China headquarters AsiaInfo Services ...
- Research articles 2007-11-16
- Tapping the team synergy.(Eli Lilly's Product Development Laboratories, Indianapolis)
- Eli Lilly cut costs and delivery time by providing incentives and encouraging early input from designers and contractors Pharmaceutical manufacturer Eli Lilly and Co. set ambitious budget and project delivery goals when it decided to consolidat Eli Lilly cut costs...
- Research articles 1998-08-01
- ELI LILLY AND COMPANY ACCELERATES CHINA EXPANSION
- AsiaInfo Services 12-20-2005 Eli Lilly and Company Accelerates China Expansion CHINA, Dec 20, 2005 SinoCast via COMTEX -- Eli Lilly and Company, which has not shaken off the Gemzar lawsuit, presented a new cancer drug Alimta in China recently AsiaInfo...
- Research articles 2005-12-20
- ELI LILLY AND COMPANY APPROVED TO LAUNCH CIALIS IN CHINA
- AsiaInfo Services 04-20-2005 Eli Lilly and Company Approved to Launch Cialis in China BEIJING, Apr 20, 2005 SinoCast via COMTEX -- The US medicine producer Eli Lilly and Company has received approval to roll out Cialis, a new product for curi...
- Research articles 2005-04-20
- ELI LILLY AND COMPANY LAUNCHES CIALIS IN CHINA
- AsiaInfo Services 06-03-2005 Eli Lilly and Company Launches Cialis in China BEIJING, Jun 03, 2005 SinoCast via COMTEX -- The US medicine producer Eli Lilly and Company posted an announcement that it has launched Cialis,the product for curing AsiaInfo...
- Research articles 2005-06-03
- ELI LILLY TO FUEL EXPANSION IN CHINA
- AsiaInfo Services 03-27-2008 Eli Lilly to Fuel Expansion in China BEIJING, Mar 27, 2008 SinoCast via COMTEX -- US-based pharmaceutical giant Eli Lilly and Company (NYSE: LLY) prefers to cooperate with Chinese pharmaceutical manufacturers rather t AsiaInfo Services 03-27-2008 Eli...
- Research articles 2008-03-27
- Eli Lilly: Well Poised for Long Term Growth
- Eli Lilly LLY, a US$36.47B firm, founded in 1876, manufactures and sells products in two business segment – Pharmaceutical Products and Animal Health Business Segment. It sells its products in US and in 135 other countries. Total global market size for pharmaceutical products alone is about US$650BN, in...
- External links 2008-11-26
- Fitch Affirms Eli Lilly & Co.'s 'AA' Senior Unsecured Rating
- CHICAGO -- Fitch Ratings has affirmed Eli Lilly and Co.'s Lilly 'AA' senior unsecured debt rating and 'F1+' commercial paper rating. Simultaneously, Fitch has assigned an 'AA' bank loan rating and an 'AA' rating to Eli Lilly Services, Inc.'s Eli Lilly Services private issuance of $1.5 billion of extendible 13-month...
- Research articles 2005-08-25
- Eli Lilly and Company. (Jobs and People).(appointments)(Brief Article)
- * Anne Nobles has been named vice president of corporate affairs at Eli Lilly and Company. * ... * Anne Nobles has been named vice president of corporate affairs at Eli Lilly and Company. ...
- Research articles 2003-06-09
- The Lesson From Eli Lilly's Privacy Woes: Practice What You Preach
- This article discusses some lesson from Eli Lilly's privacy woes. The Federal Trade Commission FTC recently announced a settlement with Eli Lilly Lilly for deceptive and unfair practices stemming from that company's one-time, accidental release of 669 e-mail addresses. The e-mail addresses identified customers of Lilly who had signed up...
- White papers 2002-03-01
- Eli Lilly, BI form drug pact in stress urinary incontinence. (Life Sciences).(Boehringer Ingelheim GmbH)
- ELI LILLY and Company has inked a long-term agreement with Boehringer Ingelheim GmbH BI to jointly commercialize duloxetine, a key player in Lilly's crowded pipeline. The pact, Lilly's first major copromotion deal for an in-house product, lays th ELI LILLY and Company has inked...
- Research articles 2002-12-16
- Eli Lilly Sued Over Evista.(Brief Article)
- ZENECA INC. has filed suit against Eli Lilly and Company over Lilly's promotion of its osteoporosis drug, Evista raloxifene, claiming that Lilly is making misleading claims about the drug's effectiveness in reducing breast cancer. Zeneca alleges ZENECA INC. has filed suit against Eli...
- Research articles 1999-03-08
- Lilly Gets Temporary Prozac Reprieve.(Eli Lilly and Co.'s Prozac patent extended)(Brief Article)
- THE FOOD AND Drug Administration has extended Eli Lilly & Co.'s patent on the antidepressant Prozac fluoxetine for an additional six months. The extension was granted since Lilly agreed to test the antidepressant on children. Under the ...
- Research articles 2000-11-20
- ELI LILLY & CO.(forms Lilly Bio Ventures)(Brief Article)
- ELI LILLY & CO. has formed an early-stage biotech venture firm, Lilly Bio Ventures, with initial funding of $75 million. Also, the approval process for Xigris ... ELI LILLY & CO. has formed an early-stage biotech venture firm, Lilly Bio Ventures, with initial funding...
- Research articles 2001-10-01
- Lilly Hopes Sepsis Drug Will Cushion Prozac Expiry.(Eli Lilly and Co.)(Prozac's patent expiration)(Brief Article)
- Zovant would be the first treatment for the disease. ELI LILLY & Co. has developed a promising new drug, recombinant human activated protein C APC, to treat sepsis, a previously untreatable condition. Although Lilly has yet to file with ...
- Research articles 2000-11-27
- SANOFI-SYNTHELABO.(Purchases Eli Lilly's share in Sanofi Lilly Oncology)(Brief Article)
- SANOFI-SYNTHELABO has purchased Eli Lilly and Co.'s share of its US-based joint venture Sanofi Lilly Oncology LLC, recovering full rights to oxaliplatin in the US. The two companies formed a ... SANOFI-SYNTHELABO has purchased Eli Lilly and Co.'s share of its US-based joint venture...
- Research articles 2000-10-30
- Eli Lilly heads for Israel. (Eli Lilly and Company)
- One of the world's largest multinational pharmaceutical companies, U.S.-based Eli Lilly, has decided to establish a subsidiary in Israel. A spokesperson for the U.S. company said that the move is part of its international strategy to establish great One of the world's largest multinational pharmaceutical...
- Research articles 1997-04-15
- ELI LILLY.(Eli Lilly and Co.)(Brief Article)
- ELI LILLY and Company will invest more than $48 million in new research facilities at its Greenfield Laboratories in Indiana. The move ... ELI LILLY and Company will invest more than $48 million in new research facilities at its Greenfield Laboratories in Indiana. The...
- Research articles 2000-12-11
- Eli Lilly & Co.(Brief Article)
- 00-00-0000 for fiscal 1997 Eli Lilly's sales reached $8.5 billion, a 16% increase over the previous year. Three quarters of this increase came from new-product sales. The maker of Prozac, the most popular antidepressant of the decade, Eli Lilly has 00-00-0000 for...
- Research articles 1998-08-17
- << Previous
- page 1 of 67
- Next >>
Content Types
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
